UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000011704
Receipt number R000013560
Scientific Title The effect of electrical stimulation generated by neuromuscular transmission monitor to the HT7 acupuncture point on preventing emergence agitation in children. A prospective double-blind randomized controlled trial.
Date of disclosure of the study information 2013/09/14
Last modified on 2014/03/12 21:15:31

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The effect of electrical stimulation generated by neuromuscular transmission monitor to the HT7 acupuncture point on preventing emergence agitation in children. A prospective double-blind randomized controlled trial.

Acronym

The effect of electrical stimulation generated by neuromuscular transmission monitor to the HT7 acupuncture point on preventing emergence agitation in children. A prospective double-blind randomized controlled trial.

Scientific Title

The effect of electrical stimulation generated by neuromuscular transmission monitor to the HT7 acupuncture point on preventing emergence agitation in children. A prospective double-blind randomized controlled trial.

Scientific Title:Acronym

The effect of electrical stimulation generated by neuromuscular transmission monitor to the HT7 acupuncture point on preventing emergence agitation in children. A prospective double-blind randomized controlled trial.

Region

Japan


Condition

Condition

Pediatric patients who are scheduled to undergo surgery under general anesthesia.

Classification by specialty

Anesthesiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Our aim is to detect the effect of electrical stimulation using neuromuscular transmitter monitoring device (NTM) to the heart 7 (HT7) acupoint for preventing emergence agitation in pediatric patients in this prospective, double-blind, randomized controlled study.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

incidence of emergence agitation under general anesthesia with sevoflurane in children

Key secondary outcomes

rescue drug use for the emergence agitation, rescue drug use for the postoperative pain, severity of the agitation, and severity of the pain


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification

YES

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

YES

Concealment

Numbered container method


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

HT7 stimulation group:
we plan to stimulate both right and left sides of HT7 acupuncture site using neuromuscular transmission monitor (TOFwatch). Single-twitch stimulation with 1 Hz (over 0,2 ms, at a constant current of 50 mA) was applied for the group throughout operation.

Interventions/Control_2

Control group:
The NTM electrode attachments are placed on all subject at both left and right hand of HT7 acupuncture site, but electrical stimulation is not applied.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 months-old <=

Age-upper limit

96 months-old >=

Gender

Male and Female

Key inclusion criteria

ASA 1 or 2
Patients who are scheduled to undergo surgery under general anesthesia with sevoflurane

Key exclusion criteria

Children with developmental delay psychological or neurological disorders, abnormal airway, or reactive airway disease, are excluded

Target sample size

130


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Toshiyuki Hijikata

Organization

Kanagawa children's medical center

Division name

Department of Anesthesiology

Zip code


Address

Mutsukawa 2-138-4, Minami-ku, Yokohama Kanagawa, Japan

TEL

045-711-2351

Email

th.1984.06.01@gmail.com


Public contact

Name of contact person

1st name
Middle name
Last name Takahiro Mihara

Organization

Kanagawa children's medical center

Division name

Department of Anesthesiology

Zip code


Address

Mutsukawa 2-138-4, Minami-ku, Yokohama Kanagawa, Japan

TEL

045-711-2351

Homepage URL

http://kanagawa-pho.jp/osirase/byouin/kodomo/

Email

miharaxxxtotoro@yahoo.co.jp


Sponsor or person

Institute

Kanagawa children's medical center

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

Kanagawa children's medical center


Other administrative information

Date of disclosure of the study information

2013 Year 09 Month 14 Day


Related information

URL releasing protocol

http://kanagawa-pho.jp/osirase/byouin/kodomo/

Publication of results

Partially published


Result

URL related to results and publications

http://kanagawa-pho.jp/osirase/byouin/kodomo/

Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2013 Year 09 Month 05 Day

Date of IRB


Anticipated trial start date

2013 Year 09 Month 10 Day

Last follow-up date

2014 Year 03 Month 10 Day

Date of closure to data entry


Date trial data considered complete

2013 Year 03 Month 31 Day

Date analysis concluded

2013 Year 03 Month 31 Day


Other

Other related information



Management information

Registered date

2013 Year 09 Month 11 Day

Last modified on

2014 Year 03 Month 12 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000013560


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name